The liver is the largest solid internal organ in the human body, situated in the right upper quadrant of the abdomen beneath the diaphragm. It receives a dual blood supply: the hepatic artery delivers oxygenated blood from the systemic circulation, while the portal vein brings nutrient-rich, deoxygenated blood directly from the gastrointestinal tract and spleen. Inside the liver, functional units called lobules process these blood supplies through specialized cells known as hepatocytes.
The liver performs vital metabolic, synthetic, and detoxifying functions essential for life.
Liver diseases stem from diverse origins, encompassing infectious, metabolic, toxic, and autoimmune etiologies. When hepatic tissue suffers chronic injury, hepatocytes undergo necrosis and are eventually replaced by fibrous scar tissue. This scarring distorts the normal lobular architecture, impairing both blood flow and cellular function. Common categories of liver disease include viral infections, alcohol-related liver disease, non-alcoholic fatty liver disease (NAFLD), drug-induced liver injury, and inherited metabolic conditions.
Viral hepatitis involves inflammation of the liver parenchyma caused by specific hepatotropic viruses, primarily types A, B, C, D, and E. Each virus exhibits unique transmission routes and clinical trajectories.
Clinical manifestations often progress through distinct phases. The prodromal or pre-icteric phase features fatigue, anorexia, right upper quadrant discomfort, and low-grade fever. The icteric phase brings jaundice, dark urine, and pale stools due to conjugated hyperbilirubinemia. Finally, the convalescent phase marks the gradual fading of jaundice and return of appetite.
Cirrhosis represents the late stage of progressive hepatic fibrosis, characterized by the replacement of normal liver tissue with regenerative nodules surrounded by fibrous scar tissue. This structural disruption severely increases resistance to blood flow moving through the liver, leading to portal hypertension.
Elevated pressure within the portal venous system forces blood to seek alternative pathways back to the heart, creating collateral vessels known as varices. These fragile varices frequently develop in the lower esophagus, stomach, and rectum, carrying a life-threatening risk of rupture and massive gastrointestinal bleeding. Portal hypertension also contributes heavily to splenomegaly, fluid retention, and systemic circulatory changes.
As liver function deteriorates, severe complications emerge that affect neurological and fluid status. Ascites is the pathological accumulation of fluid within the peritoneal cavity. It results from a combination of portal hypertension, low serum albumin levels (reduced oncotic pressure), and renal retention of sodium and water via secondary hyperaldosteronism.
Hepatic encephalopathy is a complex neurological syndrome caused by the liver's inability to detoxify metabolic byproducts. Chief among these is ammonia, a neurotoxin absorbed from the gut that bypasses the failing liver through shunts and crosses the blood-brain barrier. Clinically, this manifests as personality changes, confusion, lethargy, and a characteristic flapping tremor of the hands known as asterixis.
Clinicians use a combination of blood tests, imaging modalities, and tissue sampling to assess liver health and determine the extent of injury.
| Test Category | Specific Markers / Methods | Clinical Significance |
|---|---|---|
| Liver Enzymes | AST, ALT, ALP | Elevated levels indicate hepatocellular injury or biliary obstruction. |
| Synthetic Function | Serum Albumin, PT/INR | Low albumin and prolonged clotting times reflect impaired protein synthesis. |
| Excretory Function | Total and Conjugated Bilirubin | Elevated levels indicate impaired bile excretion, causing jaundice. |
| Imaging | Ultrasound, CT, MRI | Identifies organ size, fatty infiltration, ascites, and structural nodules. |
| Histology | Liver Biopsy | Provides definitive staging of inflammation and degree of fibrosis. |
Treatment strategies for hepatic disorders aim to halt underlying disease progression, manage acute complications, and relieve symptoms. For viral hepatitis, antiviral medications suppress viral replication. In ascites management, dietary sodium restriction combined with diuretic therapy (such as spironolactone and furosemide) helps control fluid buildup. Large-volume paracentesis may be performed to drain tense ascites.
To manage hepatic encephalopathy, lactulose is administered orally or rectally. Lactulose lowers intestinal pH, converting ammonia into ammonium, which is then trapped in the gut and excreted in stool. Antibiotics like rifaximin are also used to reduce ammonia-producing bacteria in the intestinal tract. Esophageal varices are managed with beta-blockers to lower portal pressure and endoscopic band ligation to prevent or treat bleeding episodes.
Comprehensive nursing care for clients with liver disorders focuses on monitoring complications, providing supportive interventions, and delivering targeted education. Nurses must regularly assess neurological status for early signs of encephalopathy, monitor abdominal girth and daily weight for fluid retention, and observe all stool and emesis for occult or frank blood.
Dietary counseling is vital: clients with ascites require strict sodium restriction, while those with encephalopathy may need temporary protein modification. Nurses must instruct patients to completely avoid alcohol, hepatotoxic over-the-counter medications like paracetamol, and raw shellfish, which carries high infection risks in immunocompromised cirrhotic clients. Clear discharge instructions ensure that patients recognize emergency warning signs such as hematemesis, worsening confusion, or rapid abdominal swelling.